Skip to Content
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 22, Issue 5

2015 October - 29 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (29)

  • Article
  • Open Access
16 Citations
1,028 Views
9 Pages

Using a Family History Questionnaire to Identify Adult Patients with Increased Genetic Risk for Sarcoma

  • A. Schiavi,
  • J. Lavigne,
  • R. Turcotte,
  • L. Kasprzak,
  • N. Dumas,
  • G. Chong,
  • C. Freeman,
  • M. Alameldin,
  • P. Galiatsatos and
  • W.D. Foulkes
  • + 1 author

1 October 2015

Background: Sarcomas in adults can be associated with hereditary cancer syndromes characterized by early-onset predisposition to numerous types of cancer. Because of variability in familial presentation and the largely unexplained genetic basis of sa...

  • Article
  • Open Access
7 Citations
843 Views
7 Pages

Population-Based Estimates of Survival and Cost for Metastatic Melanoma

  • C.E. McCarron,
  • S. Ernst,
  • J.Q. Cao and
  • G.S. Zaric

1 October 2015

Background: Fewer than half of all patients with metastatic melanoma survive more than 1 year. Standard treatments have had little success, but recent therapeutic advances offer the potential for an improved prognosis. In the present study, we used p...

  • Article
  • Open Access
11 Citations
1,164 Views
8 Pages

1 October 2015

Introduction: Stage iii lung cancer is the most advanced stage of lung cancer for which radical (potentially curative) treatment is often discussed. Understanding the reasons for mortality and subsequent treatments in patients with stage iii non-smal...

  • Article
  • Open Access
47 Citations
1,683 Views
15 Pages

Quality of End-of-Life Cancer Care in Canada: A Retrospective Four-Province Study Using Administrative Health Care Data

  • L. Barbera,
  • H. Seow,
  • R. Sutradhar,
  • A. Chu,
  • F. Burge,
  • K. Fassbender,
  • K. McGrail,
  • B. Lawson,
  • Y. Liu and
  • A. Potapov
  • + 1 author

1 October 2015

Background: The quality of data comparing care at the end of life (eol) in cancer patients across Canada is poor. This project used identical cohorts and definitions to evaluate quality indicators for eol care in British Columbia, Alberta, Ontario, a...

  • Article
  • Open Access
25 Citations
1,077 Views
5 Pages

The Changing Landscape of Brachytherapy for Cervical Cancer: A Canadian Practice Survey

  • T. Phan,
  • L. Mula-Hussain,
  • S. Pavamani,
  • A. Pearce,
  • D. D’Souza,
  • N.G. Patil,
  • L. Traptow and
  • C.M. Doll

1 October 2015

Background: We documented changes in practice from 2009 to 2012 for cervical cancer brachytherapy in Canada. Methods: Centres with gynecologic brachytherapy services were sent an e-mail questionnaire querying their 2012 practice. Responses are report...

  • Short Communication
  • Open Access
12 Citations
1,150 Views
4 Pages

Wait Times for Prostate Cancer Treatment and Patient Perceptions of Care in Canada: A Mixed-Methods Report

  • K. Tran,
  • C. Sandoval,
  • R. Rahal,
  • G. Porter,
  • R. Siemens,
  • J. Hernandez,
  • S. Fung,
  • C. Louzado,
  • J Liu and
  • in collaboration with the System Performance Steering Committee and Technical Working Group
  • + 1 author

1 October 2015

Background: Access to cancer care is a significant concern for Canadians. Prolonged delays between cancer diagnosis and treatment have been associated with anxiety, stress, and perceived powerlessness for patients and their family members. Longer wai...

  • Article
  • Open Access
49 Citations
1,503 Views
6 Pages

Pleural Fluid Tumour Markers in Malignant Pleural Effusion with Inconclusive Cytologic Results

  • L. Antonangelo,
  • R.K. Sales,
  • A.P. Corá,
  • M.M.P. Acencio,
  • L.R. Teixeira and
  • F.S. Vargas

1 October 2015

Background: The presence of tumour cells in pleural fluid or tissue defines an effusion as malignant. Cytology analysis of the pleural fluid has about 60% diagnostic sensitivity. Several tests have been proposed to improve diagnosis—among them, the c...

  • Article
  • Open Access
10 Citations
1,192 Views
7 Pages

Physician Preferences for Bone Metastasis Drug Therapy in Canada

  • J. Arellano,
  • J.M. González,
  • Y. Qian,
  • M. Habib,
  • A.F. Mohamed,
  • F. Gatta,
  • A.B. Hauber,
  • J. Posner,
  • N. Califaretti and
  • E. Chow

1 October 2015

Background: Currently in Canada, several bone-targeted agents (BTAS) with varying characteristics are available for the prevention of skeletal-related events (SRES) in patients with bone metastasis secondary to solid tumours. In the present study, we...

  • Article
  • Open Access
8 Citations
934 Views
8 Pages

1 October 2015

Background: Metastatic colorectal cancer (MCRC) commonly affects elderly people, an understudied subset of patients. We analyzed the survival impact of the first and subsequent lines of chemotherapy in eligible non-trial patients 70 years of age and...

  • Article
  • Open Access
8 Citations
1,249 Views
7 Pages

Human Albumin Eye Drops as a Therapeutic Option for the Mmanagement of Keratoconjunctivitis Sicca Secondary to Chronic Graft-Versus-Host Disease after Stem-Cell Allografting

  • J.T. Seki,
  • N. Sakurai,
  • S. Moldenhauer,
  • J. Dam,
  • E.G. Atenafu,
  • P.M. Yip,
  • T. Mazzulli,
  • T. Henderson,
  • J. Pendergrast and
  • J.H. Lipton
  • + 5 authors

1 October 2015

Background:Keratoconjunctivitis sicca from chronic graft-versus-host disease (cgvhd) after allogeneic stem cell transplantation is common, leading to severe corneal damage and blindness if not treated. We retrospectively examined the efficacy and saf...

  • Article
  • Open Access
20 Citations
1,234 Views
6 Pages

1 October 2015

Background: Patient education in early-stage breast cancer has been shown to improve patient well-being and quality of life, but it poses a challenge given the increasingly complex regimens and time constraints in clinical practice. Technology-aided...

  • Article
  • Open Access
9 Citations
1,206 Views
6 Pages

Preliminary Results of Proton-Beam Therapy for Stage iii Non-Small-Cell Lung Cancer

  • Y. Hatayama,
  • T. Nakamura,
  • M. Suzuki,
  • Y. Azami,
  • T. Ono,
  • H. Yamaguchi,
  • Y. Hayashi,
  • I. Tsukiyama,
  • M. Hareyama and
  • Y. Takai
  • + 1 author

1 October 2015

Background: We conducted a preliminary retrospective evaluation of the efficacy and toxicity of proton-beam therapy (pbt) for stage iii non-small-cell lung cancer. Methods: Between January 2009 and August 2013, 27 patients (26 men, 1 woman) with stag...

  • Short Communication
  • Open Access
8 Citations
841 Views
3 Pages

To Screen or Not to Screen for Breast Cancer? How Do Modelling Studies Answer the Question?

  • R.G. Koleva-Kolarova,
  • Z. Zhan,
  • M.J.W. Greuter,
  • T.L. Feenstra and
  • G.H. De Bock

1 October 2015

Breast cancer screening is a topic of hot debate, and currently no general consensus has been reached on starting and ending ages and screening intervals, in part because of a lack of precise estimations of the benefit–harm ratio. Simulation models a...

  • Case Report
  • Open Access
2 Citations
767 Views
4 Pages

1 October 2015

Perivascular epithelioid cell tumours (PEComas) are rare mesenchymal tumours that are characterized by perivascular epithelioid cell differentiation and immunoreactivity to myogenic and melanocytic markers. These tumours can be classified as benign,...

  • Case Report
  • Open Access
7 Citations
990 Views
4 Pages

1 October 2015

Primary intravascular synovial sarcoma is a rare malignancy with only a few cases documented in the literature. On presentation, this tumour usually resembles a deep venous thrombosis (dvt) or pulmonary embolism (pe). Here, we report the case of a 20...

  • Case Report
  • Open Access
3 Citations
958 Views
4 Pages

1 October 2015

Thymic carcinoma is a rare but lethal mediastinal cancer. The optimal treatment for advanced thymic carcinoma is not yet established. This report is the first known of stereotactic ablative radiotherapy (sabr) with CyberKnife (Accuray, Sunnyvale, CA,...

  • Case Report
  • Open Access
11 Citations
1,006 Views
5 Pages

1 October 2015

Kaposi sarcoma (ks) is a vascular tumour caused by oncogenic human herpesvirus type 8; it often occurs with hiv-associated immunosuppression. Numerous cellular signalling pathways are involved in the pathogenesis of ks, among which receptor tyrosine...

  • Letter
  • Open Access
4 Citations
671 Views
3 Pages

1 October 2015

In his editorial and perspective, Dr. Constantine Kaniklidis covers a lot of ground, and there is much to agree with. Certainly, we should be moving forward to find and evaluate better ways of detecting, characterizing, and treating breast (and other...

  • Editorial
  • Open Access
586 Views
2 Pages

1 October 2015

The packed snow yielded its familiar crunch with every step I took. Behind me, the winter daylight faded as darkness crept through the cloudless sky. With each step forward, the brick walls of the cancer centre loomed larger ahead. This was my destin...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729